FDA Issues
FDA Home Page
FDA Fact Sheet
Bill Allows FDA to Regulate Tobacco
FDA Consumer Alert Tainted Skin Sanitizer
FDA Health Care Professionals Information
FDA OxyContin Press Release with FAQ
FDA Drug Safety Communication: Stalevo
FDA under the BRILINTA Risk Evaluation and Mitigation Strategy (REMS)
Decreased Efficacy with BRILINTA
FDA Acts Against 5 Electronic Cigarettes Distributors
FDA Orders Halt To Marketing Of Unapproved Single-Ingredient Oral Colchicine
FDA Approves Injectable Drug to Treat Opioid-Dependent Patients
FDA Announces Recall Of Abbott Glucose Test Strips
FDA Possible Increased Risk Of Thigh Bone Fracture With Bisphosphonates
For Release click here:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm
Notice to Healthcare Professionals from FDA
FDA Approves Levemir